Agustin Melian - Sep 28, 2021 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
Chief Medical Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Stock symbol
ALVR
Transactions as of
Sep 28, 2021
Transactions value $
-$90,432
Form type
4
Date filed
9/29/2021, 04:15 PM
Previous filing
Sep 20, 2021
Next filing
Oct 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale -$90.4K -3.75K -0.79% $24.12* 472K Sep 28, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.